{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T07:19:16Z","timestamp":1720163956364},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,31]]},"DOI":"10.7759\/cureus.25522","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T12:17:57Z","timestamp":1653999477000},"source":"Crossref","is-referenced-by-count":1,"title":["Adherence to Antiretroviral Therapy Among HIV-Infected Clients Attending Opioid Treatment Program Clinics in Dar es Salaam, Tanzania"],"prefix":"10.7759","author":[{"given":"John","family":"Kizindo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alphonce  I","family":"Marealle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritah","family":"Mutagonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamu J","family":"Mlyuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wigilya  P","family":"Mikomangwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manase","family":"Kilonzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael Z","family":"Sangeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"UN Joint Programme on HIV\/AIDS (UNAIDS). Global HIV statistics. (2020). . (2020). Accessed: 17\/5\/2022: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf, 1-6. ."},{"key":"ref2","unstructured":"AVERT. HIV and AIDS in East and Southern Africa regional overview. (2019). Accessed: May 17, 2022. https:\/\/www.avert.org\/printpdf\/node\/393.."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.2009.21.5.474","article-title":"HIV seroprevalence in a sample of Tanzanian intravenous drug users","volume":"21","author":"Williams ML","year":"2009","unstructured":"Williams ML, McCurdy SA, Bowen AM, Kilonzo GP, Atkinson JS, Ross MW, Leshabari MT. HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Educ Prev. 2009, 21:474-83. 10.1521\/aeap.2009.21.5.474","journal-title":"AIDS Educ Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145578","article-title":"Epidemiology of drug use and HIV-related risk behaviors among people who inject drugs in Mwanza, Tanzania","volume":"10","author":"Tan AX","year":"2015","unstructured":"Tan AX, Kapiga S, Khoshnood K, Bruce RD. Epidemiology of drug use and HIV-related risk behaviors among people who inject drugs in Mwanza, Tanzania. PLoS One. 2015, 10:e0145578. 10.1371\/journal.pone.0145578","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-6-24","article-title":"Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review","volume":"6","author":"Reid SR","year":"2009","unstructured":"Reid SR. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J. 2009, 6:24. 10.1186\/1477-7517-6-24","journal-title":"Harm Reduct J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000555","article-title":"Prevalence and predictors of human immunodeficiency virus and selected sexually transmitted infections among people who inject drugs in Dar es Salaam, Tanzania: a new focus to get to zero","volume":"44","author":"Mmbaga EJ","year":"2017","unstructured":"Mmbaga EJ, Moen K, Makyao N, Leshabari M. Prevalence and predictors of human immunodeficiency virus and selected sexually transmitted infections among people who inject drugs in Dar es Salaam, Tanzania: a new focus to get to zero. Sex Transm Dis. 2017, 44:79-84. 10.1097\/OLQ.0000000000000555","journal-title":"Sex Transm Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16050728","article-title":"Evaluating the integrated methadone and anti-retroviral therapy strategy in Tanzania using the RE-AIM framework","volume":"16","author":"Hassan S","year":"2019","unstructured":"Hassan S, Cooke A, Saleem H, Mushi D, Mbwambo J, Lambdin BH. Evaluating the integrated methadone and anti-retroviral therapy strategy in Tanzania using the RE-AIM framework. Int J Environ Res Public Health. 2019, 16:10.3390\/ijerph16050728","journal-title":"Int J Environ Res Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.003","article-title":"Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy","volume":"84","author":"Palepu A","year":"2006","unstructured":"Palepu A, Tyndall MW, Joy R, et al.. Antiretroviral adherence and HIV treatment outcomes among HIV\/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006, 84:188-94. 10.1016\/j.drugalcdep.2006.02.003","journal-title":"Drug Alcohol Depend"},{"key":"ref9","article-title":"Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users","volume":"169","author":"Wood E","year":"2003","unstructured":"Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ. 2003, 169:656-61.","journal-title":"CMAJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0928-3","article-title":"Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: an international systematic review","volume":"19","author":"Feelemyer J","year":"2015","unstructured":"Feelemyer J, Des Jarlais D, Arasteh K, Uusk\u00fcla A. Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: an international systematic review. AIDS Behav. 2015, 19:575-83. 10.1007\/s10461-014-0928-3","journal-title":"AIDS Behav"},{"key":"ref11","article-title":"Tanzania in Figures 2012","author":"National Beaural of Statistics","year":"2013","unstructured":"National Beaural of Statistics. Tanzania in Figures 2012. Ministry of Finance, United Republic of Tanzania, Das es Salaam; 2013."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42:377-81. 10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019, 95:103208. 10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/09540120050042891","article-title":"Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG)","volume":"12","author":"Chesney MA","year":"2000","unstructured":"Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000, 12:255-66. 10.1080\/09540120050042891","journal-title":"AIDS Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-1035","article-title":"Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings","volume":"14","author":"Sangeda RZ","year":"2014","unstructured":"Sangeda RZ, Mosha F, Prosperi M, et al.. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health. 2014, 14:1035. 10.1186\/1471-2458-14-1035","journal-title":"BMC Public Health"},{"key":"ref16","unstructured":"United Republic of Tanzania. National Guidelines for the management of HIV and AIDS in Tanzania. (2019). Accessed: May 30, 2021: http:\/\/www.nacp.go.tz\/download\/national-guidelines-for-the-management-of-hiv-and-aids\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1086\/323201","article-title":"Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring","volume":"33","author":"Arnsten JH","year":"2001","unstructured":"Arnsten JH, Demas PA, Farzadegan H, et al.. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001, 33:1417-23. 10.1086\/323201","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199906180-00014","article-title":"The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group","volume":"13","author":"Haubrich RH","year":"1999","unstructured":"Haubrich RH, Little SJ, Currier JS, et al.. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS. 1999, 13:1099-107. 10.1097\/00002030-199906180-00014","journal-title":"AIDS"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2011.0196","article-title":"Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users","volume":"26","author":"Hadland SE","year":"2012","unstructured":"Hadland SE, Milloy MJ, Kerr T, et al.. Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users. AIDS Patient Care STDS. 2012, 26:274-80. 10.1089\/apc.2011.0196","journal-title":"AIDS Patient Care STDS"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.26719\/2018.24.3.237","article-title":"Adherence to antiretroviral therapy in HIV-positive, male intravenous drug users in Pakistan","volume":"24","author":"Ali B","year":"2018","unstructured":"Ali B, Nisar N, Nawab F. Adherence to antiretroviral therapy in HIV-positive, male intravenous drug users in Pakistan. East Mediterr Health J. 2018, 24:237-42. 10.26719\/2018.24.3.237","journal-title":"East Mediterr Health J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/09540120701426516","article-title":"Reasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi","volume":"19","author":"Amico KR","year":"2007","unstructured":"Amico KR, Konkle-Parker DJ, Cornman DH, et al.. Reasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi. AIDS Care. 2007, 19:1210-8. 10.1080\/09540120701426516","journal-title":"AIDS Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/270914","article-title":"Missed doses and missed appointments: adherence to ART among adult patients in Uganda","volume":"2013","author":"Shumba C","year":"2013","unstructured":"Shumba C, Atuhaire L, Imakit R, Atukunda R, Memiah P. Missed doses and missed appointments: adherence to ART among adult patients in Uganda. ISRN AIDS. 2013, 2013:270914. 10.1155\/2013\/270914","journal-title":"ISRN AIDS"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S143178","article-title":"Predictors of non adherence to antiretroviral therapy at an urban HIV care and treatment center in Tanzania","volume":"10","author":"Sangeda RZ","year":"2018","unstructured":"Sangeda RZ, Mosha F, Aboud S, et al.. Predictors of non adherence to antiretroviral therapy at an urban HIV care and treatment center in Tanzania. Drug Healthc Patient Saf. 2018, 10:79-88. 10.2147\/DHPS.S143178","journal-title":"Drug Healthc Patient Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/98974-adherence-to-antiretroviral-therapy-among-hiv-infected-clients-attending-opioid-treatment-program-clinics-in-dar-es-salaam-tanzania","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:59Z","timestamp":1707507359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/98974-adherence-to-antiretroviral-therapy-among-hiv-infected-clients-attending-opioid-treatment-program-clinics-in-dar-es-salaam-tanzania"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.25522","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}